Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
4.670
-0.080 (-1.68%)
At close: Jun 23, 2025, 4:00 PM
4.750
+0.080 (1.71%)
After-hours: Jun 23, 2025, 7:39 PM EDT
Candel Therapeutics Market Cap
Candel Therapeutics has a market cap or net worth of $233.98 million as of June 23, 2025. Its market cap has decreased by -2.20% in one year.
Market Cap
233.98M
Enterprise Value
152.73M
1-Year Change
-2.20%
Ranking
Category
Stock Price
$4.67
Market Cap Chart
Since the IPO on July 27, 2021, Candel Therapeutics's market cap has increased from $222.39M to $233.98M, an increase of 5.21%. That is a compound annual growth rate of 1.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 20, 2025 | 237.99M | -35.45% |
| Dec 31, 2024 | 368.69M | 767.25% |
| Dec 29, 2023 | 42.51M | -17.80% |
| Dec 30, 2022 | 51.72M | -76.95% |
| Dec 31, 2021 | 224.35M | 0.88% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.73B |
| Johnson & Johnson | 360.41B |
| AbbVie | 327.31B |
| Novo Nordisk | 326.28B |
| UnitedHealth Group | 273.97B |
| Abbott Laboratories | 231.38B |
| Novartis AG | 227.54B |
| AstraZeneca | 217.06B |